Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Jing Cao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1404-4624; OpenAlex author ID A5057843656. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper

Papers 3

  1. TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer. Co-author DOI 10.1186/s12951-022-01659-4↗
  2. Tablet-like TiO2/C nanocomposites for repeated type I sonodynamic therapy of pancreatic cancer. Co-author DOI 10.1016/j.actbio.2021.05.029↗
  3. Hypoxia-alleviated nanoplatform to enhance chemosensitivity and sonodynamic effect in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2021.07.008↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pintong Huang · 2 shared papers, 2021 · strength 0.26
  2. Youfeng Xu · 1 shared paper, 2022 · strength 0.15
  3. Libin Chen · 1 shared paper, 2022 · strength 0.15
  4. Jifan Chen · 1 shared paper, 2021 · strength 0.11
  5. Yue Hong Song · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.